Lukito Patrick Putra, July Julius, Suntoro Vanessa Angelica, Wijaya Jeremiah Hilkiah, Hamdoyo Audrey, Sindunata Nyoman Aditya, Muljadi Rusli
Department of Neurosurgery, Neuroscience Center Siloam Hospital, Tangerang, Banten, Indonesia.
Department of Radiology, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Banten, Indonesia.
Surg Neurol Int. 2023 May 26;14:182. doi: 10.25259/SNI_127_2023. eCollection 2023.
Neutrophil-lymphocyte-ratio (NLR) and platelet-lymphocyte-ratio (PLR) have emerged as potential biomarkers in predicting the outcomes of aneurysmal subarachnoid hemorrhage (aSAH). Since a study was never conducted on the Southeast Asian and Indonesian population, we designed the present study to evaluate the potential of NLR and PLR in predicting cerebral infarction and functional outcomes and find the optimal cutoff value.
We retrospectively reviewed patients admitted for aSAH in our hospital between 2017 and 2021. The diagnosis was made using a computed tomography (CT) scan or magnetic resonance imaging and CT angiography. Association between admission NLR and PLR and the outcomes were analyzed using a multivariable regression model. A receiver operating characteristic (ROC) analysis was done to identify the optimal cutoff value. A propensity score matching (PSM) was then carried out to reduce the imbalance between the two groups before comparison.
Sixty-three patients were included in the study. NLR was independently associated with cerebral infarction (odds ratio, OR 1.197 [95% confidence interval, CI 1.027-1.395] per 1-point increment; = 0.021) and poor discharge functional outcome (OR 1.175 [95% CI 1.036-1.334] per 1-point increment; = 0.012). PLR did not significantly correlate with the outcomes. ROC analysis identified 7.09 as the cutoff for cerebral infarction and 7.50 for discharge functional outcome. Dichotomizing and performing PSM revealed that patients with NLR above the identified cutoff value significantly had more cerebral infarction and poor discharge functional outcome.
NLR demonstrated a good prognostic capability in Indonesian aSAH patients. More studies should be conducted to find the optimal cutoff value for each population.
中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)已成为预测动脉瘤性蛛网膜下腔出血(aSAH)预后的潜在生物标志物。由于此前从未对东南亚和印度尼西亚人群进行过相关研究,我们设计了本研究,以评估NLR和PLR在预测脑梗死和功能预后方面的潜力,并找出最佳临界值。
我们回顾性分析了2017年至2021年间我院收治的aSAH患者。通过计算机断层扫描(CT)、磁共振成像及CT血管造影进行诊断。采用多变量回归模型分析入院时NLR和PLR与预后之间的关联。进行受试者工作特征(ROC)分析以确定最佳临界值。然后进行倾向评分匹配(PSM)以减少两组之间的不平衡,再进行比较。
本研究共纳入63例患者。NLR与脑梗死独立相关(每增加1分,比值比[OR]为1.197[95%置信区间,CI 1.027 - 1.395];P = 0.021),且与出院时功能预后不良独立相关(每增加1分,OR为1.175[95%CI 1.036 - 1.334];P = 0.012)。PLR与预后无显著相关性。ROC分析确定脑梗死的临界值为7.09,出院时功能预后的临界值为7.50。将数据二分并进行PSM分析显示,NLR高于确定临界值的患者发生脑梗死及出院时功能预后不良的情况明显更多。
NLR在印度尼西亚aSAH患者中显示出良好的预后预测能力。应开展更多研究以确定各人群的最佳临界值。